Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-24 · accession 0001579003-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-26 | 2025-11-24+ | PTCT | Jacobson Allan Steven | Dir | M - OptEx | $14.88 | +26.0K | 25.4K | New | +$386.9K |
| DM | 2025-11-26 | 2025-11-24+ | PTCT | Jacobson Allan Steven | Dir | S - Sale+OE | $82.00 | -26.0K | 19.0K | -58% | -$2.13M |
| DM | 2025-11-26 | 2025-11-24+ | PTCT | Jacobson Allan Steven | Dir | M - OptEx | $0.00 | -26.0K | 6,299 | -80% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-24 | M | A | 5,701 | $11.23 | 23,152 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-24 | S | D | 5,701 | $80.13 | 17,451 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.72 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-11-24 | M | A | 6,100 | $18.01 | 23,551 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-24 | S | D | 6,100 | $80.15 | 17,451 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.72 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2025-11-25 | M | A | 6,299 | $11.23 | 23,750 | D | — | — | |
| 6 | Common | Common Stock | 2025-11-25 | S | D | 2,264 | $82.63 | 21,486 | D | — | — | (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.00 to $82.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2025-11-25 | S | D | 700 | $85.32 | 17,451 | D | — | — | (F8) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.60 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2025-11-25 | S | D | 1,125 | $84.45 | 17,851 | D | — | — | (F5) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $84.00 to $84.81 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 9 | Common | Common Stock | 2025-11-25 | S | D | 400 | $85.24 | 17,451 | D | — | — | (F6) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.14 to $85.34 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 10 | Common | Common Stock | 2025-11-25 | M | A | 7,900 | $18.01 | 25,351 | D | — | — | |
| 11 | Common | Common Stock | 2025-11-25 | S | D | 2,460 | $82.58 | 22,891 | D | — | — | (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.00 to $82.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 12 | Common | Common Stock | 2025-11-25 | S | D | 3,502 | $83.38 | 19,389 | D | — | — | (F4) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.00 to $83.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 13 | Common | Common Stock | 2025-11-25 | S | D | 1,238 | $84.47 | 18,151 | D | — | — | (F7) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $84.00 to $84.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 14 | Common | Common Stock | 2025-11-25 | S | D | 2,510 | $83.93 | 18,976 | D | — | — | (F4) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.00 to $83.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 15 | Derivative | Stock Option (Right to Buy) | 2025-11-25 | M | D | 7,900 | $0.00 | 0 | D | $18.01 · — to 2028-01-02 | 7,900 Common Stock | (F9) Currently exercisable. |
| 16 | Derivative | Stock Option (Right to Buy) | 2025-11-25 | M | D | 6,299 | $0.00 | 0 | D | $11.23 · — to 2027-01-02 | 6,299 Common Stock | (F9) Currently exercisable. |
| 17 | Derivative | Stock Option (Right to Buy) | 2025-11-24 | M | D | 6,100 | $0.00 | 7,900 | D | $18.01 · — to 2028-01-02 | 6,100 Common Stock | (F9) Currently exercisable. |
| 18 | Derivative | Stock Option (Right to Buy) | 2025-11-24 | M | D | 5,701 | $0.00 | 6,299 | D | $11.23 · — to 2027-01-02 | 5,701 Common Stock | (F9) Currently exercisable. |